Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2016-12-06

FDA Approved: MUPIROCIN — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for mupirocin by Padagis Israel Pharmaceuticals Ltd.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mupirocin (Mupirocin)

Snippet

SUPPL AP for MUPIROCIN (MUPIROCIN)